Track Zealand Pharma A/S.'s common stock ($44M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
As of the most recent data (March 2022), ZEAL shows a common stock of $44M. Scroll down for historical charts and peer comparison views.
Tracking ZEAL's common stock over time shows whether Zealand Pharma A/S. is scaling, shrinking, or reshaping that part of the business. The current reading is $44M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this common stock page, Stockcircle has Zealand Pharma A/S.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $44M) with ownership activity and broader fundamentals.
Zealand Pharma A/S.'s common stock is $44M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.